Atlas FDA

LimFlow System

FDA premarket approval P220025/S004 · decided 2024-12-20

Approval details

PMA number
P220025
Supplement
S004
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LimFlow System
Generic name
Stent graft, infrapopliteal, venous arterialization
Applicant
LimFlow, Inc.
Date received
2024-07-23
Decision date
2024-12-20
Days to decision
150 days
Decision code
APPR
Product code
QWN
Advisory committee
Cardiovascular
Expedited review
No
Location
San Jose, CA
Statement
the use of an additional sterilization chamber for ethylene oxide sterilization at the current contract sterilization facility.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
LimFlow Vector (K260188)LimFlow, Inc.2026-03-18
LimFlow ARC (K251376)LimFlow, Inc.2025-05-31
LimFlow V-Ceiver (K242776)LimFlow, Inc.2025-02-14
LimFlow Vector (K221902)LimFlow, Inc.2022-12-21
LimFlow ARC (K221541)LimFlow, Inc.2022-08-31
LimFlow V-Ceiver (K222083)LimFlow, Inc.2022-08-09